These data from multiple ovarian cancer cell lines that differ in their p53 status provide compelling evidence to support ZNF217’s function as a critical oncogene that regulates ovarian cancer cell proliferation and metastatic potential. The gene discussed is TP53; the disease is ovarian carcinoma.